{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:05:25Z","timestamp":1788433525993,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Albuminuria is a key biomarker for cardiovascular disease and chronic kidney disease. Our study aimed to describe the prevalence of albuminuria amongst people who inject drugs in London and to test any potential associations with demographic characteristics, past diagnoses, and drug preparation and administration practices. We carried out a cross-sectional survey amongst people who use drugs in London. The main outcome measure was any albuminuria including both microalbuminuria and macroalbuminuria. Three-hundred and sixteen samples were tested by local laboratory services. Our study initially employed point-of-care testing methods but this resulted in a high number of false positives. Our findings suggest the prevalence of albuminuria amongst PWID is twice that of the general population at 19% (95%CI 15.3\u201324.0%). Risk factors associated with albuminuria were HIV (aOR 4.11 [95% CI 1.37\u201312.38]); followed by overuse of acidifier for dissolving brown heroin prior to injection (aOR 2.10 [95% CI 1.04\u20134.22]). Albuminuria is high amongst people who inject drugs compared to the general population suggesting the presence of increased cardiovascular and renal pathologies. This is the first study to demonstrate an association with acidifier overuse. Dehydration may be common amongst this population and may affect the diagnostic accuracy of point-of-care testing for albuminuria.<\/jats:p>","DOI":"10.1038\/s41598-020-63748-4","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T10:03:17Z","timestamp":1587981797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["High prevalence of albuminuria amongst people who inject drugs: A cross-sectional study"],"prefix":"10.1038","volume":"10","author":[{"given":"C. R.","family":"McGowan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Nitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Brathwaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Ciccarone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gillmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Story","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,27]]},"reference":[{"key":"63748_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1086\/320879","volume":"33","author":"EL Murphy","year":"2001","unstructured":"Murphy, E. L. et al. Risk Factors for Skin and Soft-Tissue Abscesses among Injection Drug Users: A Case-Control Study. Clin. Infect. Dis. 33, 35\u201340, https:\/\/doi.org\/10.1086\/320879 (2001).","journal-title":"Clin. Infect. Dis."},{"key":"63748_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/ckj\/sfx090","volume":"11","author":"JK Scott","year":"2018","unstructured":"Scott, J. K., Taylor, D. M. & Dudley, C. R. K. Intravenous drug users who require dialysis: causes of renal failure and outcomes. Clin. Kidney J. 11, 270\u2013274, https:\/\/doi.org\/10.1093\/ckj\/sfx090 (2018).","journal-title":"Clin. Kidney J."},{"key":"63748_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1053\/ajkd.2001.25181","volume":"38","author":"TV Perneger","year":"2001","unstructured":"Perneger, T. V., Klag, M. J. & Whelton, P. K. Recreational drug use: a neglected risk factor for end-stage renal disease. Am. J. Kidney Dis. 38, 49\u201356, https:\/\/doi.org\/10.1053\/ajkd.2001.25181 (2001).","journal-title":"Am. J. Kidney Dis."},{"key":"63748_CR4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11904-019-00463-4","volume":"16","author":"CO Hileman","year":"2019","unstructured":"Hileman, C. O. & McComsey, G. A. The Opioid Epidemic: Impact on Inflammation and Cardiovascular Disease Risk in HIV. Curr. HIV\/AIDS Rep. 16, 381\u2013388, https:\/\/doi.org\/10.1007\/s11904-019-00463-4 (2019).","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"63748_CR5","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1111\/add.14257","volume":"113","author":"M Harris","year":"2018","unstructured":"Harris, M. et al. Drawing attention to a neglected injecting-related harm: a systematic review of AA amyloidosis among people who inject drugs. Addiction 113, 1790\u20131801, https:\/\/doi.org\/10.1111\/add.14257 (2018).","journal-title":"Addiction"},{"key":"63748_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-019-0330-6","volume":"16","author":"M Harris","year":"2019","unstructured":"Harris, M. et al. Injecting-related health harms and overuse of acidifiers among people who inject heroin and crack cocaine in London: a mixed-methods study. Harm Reduct. J. 16, 60, https:\/\/doi.org\/10.1186\/s12954-019-0330-6 (2019).","journal-title":"Harm Reduct. J."},{"key":"63748_CR7","doi-asserted-by":"publisher","first-page":"2180373","DOI":"10.1155\/2018\/2180373","volume":"2018","author":"S Mihai","year":"2018","unstructured":"Mihai, S. et al. Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome. J. Immunol. Res. 2018, 2180373\u20132180373, https:\/\/doi.org\/10.1155\/2018\/2180373 (2018).","journal-title":"J. Immunol. Res."},{"key":"63748_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-014-0435-z","volume":"16","author":"E Golia","year":"2014","unstructured":"Golia, E. et al. Inflammation and cardiovascular disease: from pathogenesis to therapeutic target. Curr. atherosclerosis Rep. 16, 435, https:\/\/doi.org\/10.1007\/s11883-014-0435-z (2014).","journal-title":"Curr. atherosclerosis Rep."},{"key":"63748_CR9","unstructured":"National Institute for Health and Care Excellence (NICE). Chronic kidney disease in adults: assessment and management, https:\/\/www.nice.org.uk\/guidance\/cg182\/chapter\/1-Recommendations (2015)."},{"key":"63748_CR10","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/pubmed\/fdt117","volume":"36","author":"SDS Fraser","year":"2013","unstructured":"Fraser, S. D. S. et al. Chronic kidney disease, albuminuria and socioeconomic status in the Health Surveys for England 2009 and 2010. J. Public. Health 36, 577\u2013586, https:\/\/doi.org\/10.1093\/pubmed\/fdt117 (2013).","journal-title":"J. Public. Health"},{"key":"63748_CR11","doi-asserted-by":"publisher","unstructured":"Barzilay, J. I. et al. Hospitalization Rates in Older Adults With Albuminuria: The Cardiovascular Health Study. The Journals of Gerontology: Series A, https:\/\/doi.org\/10.1093\/gerona\/glaa020 (2020).","DOI":"10.1093\/gerona\/glaa020"},{"key":"63748_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/ije\/dyh008","volume":"33","author":"MF Yuyun","year":"2004","unstructured":"Yuyun, M. F. et al. Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. Int. J. Epidemiol. 33, 189\u2013198, https:\/\/doi.org\/10.1093\/ije\/dyh008 (2004).","journal-title":"Int. J. Epidemiol."},{"key":"63748_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12954-018-0233-y","volume":"15","author":"M Harris","year":"2018","unstructured":"Harris, M. et al. \u2018Care and Prevent\u2019: rationale for investigating skin and soft tissue infections and AA amyloidosis among people who inject drugs in London. Harm Reduction. Journal 15, 23, https:\/\/doi.org\/10.1186\/s12954-018-0233-y (2018).","journal-title":"Journal"},{"key":"63748_CR14","unstructured":"Equator Network. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. (University of Oxford, Oxford, 2019)."},{"key":"63748_CR15","unstructured":"Groundswell. Groundswell: Out of homelessness, http:\/\/groundswell.org.uk (2019)."},{"key":"63748_CR16","unstructured":"Hepatitis C Trust. The Hepatitis C Trust, http:\/\/www.hepctrust.org.uk (2019)."},{"key":"63748_CR17","unstructured":"University College London Hospitals. Find & Treat service, https:\/\/www.uclh.nhs.uk\/OurServices\/ServiceA-Z\/HTD\/Pages\/MXU.aspx] (2019)."},{"key":"63748_CR18","unstructured":"Fat, L., Mindell, J. & Roderick, P. Health Survey for England 2016 Kidney and liver disease. (Health and Social Care Information Centre, London, 2017)."},{"key":"63748_CR19","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1681\/asn.2005060584","volume":"16","author":"T Tillin","year":"2005","unstructured":"Tillin, T., Forouhi, N., McKeigue, P. & Chaturvedi, N. Microalbuminuria and coronary heart disease risk in an ethnically diverse UK population: a prospective cohort study. J. Am. Soc. Nephrol. 16, 3702\u20133710, https:\/\/doi.org\/10.1681\/asn.2005060584 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"63748_CR20","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2165\/00003495-200868070-00006","volume":"68","author":"DM Fine","year":"2008","unstructured":"Fine, D. M., Perazella, M. A., Lucas, G. M. & Atta, M. G. Renal disease in patients with HIV infection: epidemiology, pathogenesis and management. Drugs 68, 963\u2013980, https:\/\/doi.org\/10.2165\/00003495-200868070-00006 (2008).","journal-title":"Drugs"},{"key":"63748_CR21","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.drugpo.2015.04.009","volume":"26","author":"D Ciccarone","year":"2015","unstructured":"Ciccarone, D. & Harris, M. Fire in the vein: Heroin acidity and its proximal effect on users\u2019 health. Int. J. Drug. Policy 26, 1103\u20131110, https:\/\/doi.org\/10.1016\/j.drugpo.2015.04.009 (2015).","journal-title":"Int. J. Drug. Policy"},{"key":"63748_CR22","doi-asserted-by":"publisher","first-page":"107525","DOI":"10.1016\/j.drugalcdep.2019.06.027","volume":"204","author":"D Lewer","year":"2019","unstructured":"Lewer, D., Tweed, E. J., Aldridge, R. W. & Morley, K. I. Causes of hospital admission and mortality among 6683 people who use heroin: A cohort study comparing relative and absolute risks. Drug. Alcohol. Dependence 204, 107525, https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.06.027 (2019).","journal-title":"Drug. Alcohol. Dependence"},{"key":"63748_CR23","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1161\/STROKEAHA.110.581215","volume":"41","author":"M Lee","year":"2010","unstructured":"Lee, M. et al. Impact of microalbuminuria on incident stroke: a meta-analysis. Stroke 41, 2625\u20132631, https:\/\/doi.org\/10.1161\/STROKEAHA.110.581215 (2010).","journal-title":"Stroke"},{"key":"63748_CR24","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1161\/01.cir.0000031732.78052.81","volume":"106","author":"HL Hillege","year":"2002","unstructured":"Hillege, H. L. et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106, 1777\u20131782, https:\/\/doi.org\/10.1161\/01.cir.0000031732.78052.81 (2002).","journal-title":"Circulation"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63748-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63748-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63748-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T09:57:24Z","timestamp":1670320644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63748-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,27]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["63748"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-63748-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,27]]},"assertion":[{"value":"18 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. McGowan reports personal fees from European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) outside the submitted work. Dr. Nitsch reports other grants from Glaxo Smith Kline, outside the submitted work. Dr. Scott reports other from Turning Point, other from Cognisant Research, non-financial support from Academy of Medical Sciences, grants from Medical Research Council, grants from Pharmacy Research UK, outside the submitted work. Dr. Ciccarone reports grants from the US National Institutes of Heath, National Institute on Drug Abuse, during the conduct of the study; personal fees from Malinckrodt, personal fees from Nektar Therapeutics, personal fees from Celero Systems, personal fees from American Association for the Advancement of Science, outside the submitted work. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7059"}}